Live Breaking News & Updates on European seal

Propanc Biopharma, Inc.: Propanc Biopharma's CEO to Attend 43rd Meeting of the European Organization of Research & Treatment of Cancer (EORTC), Dec 15

Company's Lead Joint Researcher Professor Perán to Present Latest PRP Research Propanc Biopharma, Inc. (OTC Pink: PPCB) ("Propanc" or the "Company"), a biopharmaceutical company developing novel

Granada , Andalucísp , Spain , Italy , United-kingdom , Belgium , Spanish , Juan-antonio-marchal , Kostenloser-wertpapierhandel , Aitor-gonz , James-nathanielsz , Toledo-cutillas-msc

The European Inventor Award honours innovators in every field

The European Patent Office (EPO) celebrates the best and most innovative breakthroughs in its annual European Inventor Award, which will take place in a virtual ceremony on 21 June.

Germany , Italy , United-states , United-kingdom , Belgium , Ukraine , American , Baptiste-borowczak , Martin-skadal , Erin-smith , Victor-dewulf , Peter-hedley

Wo immer du bist, du kannst nicht fremd sein

Ein poetischer Philosoph. Zum Tod des polnischen Literaturnobelpreisträgers Czeslaw Milosz

Germany , Frankfurt , Brandenburg , California , United-states , Cracow , Malopolskie , Poland , Lithuania , France , Warsaw , L67

Fondsbranche ist gespalten: Wie grün ist Atomkraft?

Nachhaltige Finanzanlagen werden bei Anlegern immer beliebter. Die EU-Kommission streitet darüber, ob auch Atomenergie als nachhaltig gelten soll. Die deutsche Fondsbranche ist sich ebenfalls uneins.

Germany , France , German , Nuclear-waste , Such-as-green-is-nuclear-power , Opinion-research-institute-forsa , Nuclear-disaster , Daughter-nuclear-energy , German-fund-companies , S-use-of-nuclear-power , S-assessment-of-nuclear-power

Propanc Biopharma Publishes Key Data in Peer Reviewed Journal Confirming Anti-Tumor Potential of Proenzymes

Current Research Shows Proenzymes Decreases Cell Proliferation and Migration, Induces Cell Differentiation, Impairs Angiogenesis and Reduces the Metastatic Potential of Cancer Stem CellsMELBOURNE, Australia (BUSINESS WIRE) Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering

Granada , Andalucísp , Spain , Shanghai , China , Melbourne , Victoria , Australia , Spanish , James-nathanielsz , Julian-kenyon , International-studyportals-organization